Probiotics
GLU70
GLU70 is our patented strain that breaks down gluten, the insoluble protein found in wheat flour, while also helping to prevent, improve, or potentially treat inflammatory bowel conditions caused by gluten.
Gluten, mainly consumed through wheat-based foods, is known to be difficult to digest and to trigger inflammation in the small and large intestine. GLU70 addresses this by breaking gluten into digestible components, alleviating intestinal inflammation, and supporting the recovery of intestinal mucosal cells.
Research on GLU70 showed that it improved intestinal mucosal damage caused by gliadin, reduced inflammation, and increased pancreatic digestive enzyme activity. These results suggest that GLU70 may help improve intestinal conditions linked to inflammation while also preventing the harmful effects of undigested gluten such as gliadin, which the body’s own enzymes cannot fully break down. By aiding gluten digestion, GLU70 helps lower gluten buildup in the body and reduce its effect as a source of ongoing inflammation.
Strain
Lactobacillus paracasei GLU70
Type
Live strain
Specification
10^6 ~ 10^11 CFU/g
Registered Applications
Probiotics (health functional foods), general food additives
Patent (1)
Title: Composition containing Lactobacillus paracasei GLU70 with gluten-degrading properties for the prevention, improvement, or treatment of inflammatory bowel disease caused by gliadin
Publications (2)
1) Biochemical properties and gluten degradation of Lactobacillus paracasei strain GLU70
isolated from salted seafood. Korean J. Food Sci. Technol. (2022).
2) Changes in inflammatory cytokine and gene expression in the intestines of
gliadin-administered mice following gluten-degrading strain GLU70 intake. Korean J. Food Sci. Technol. (2024).
MB0601
MB0601 is a patented probiotic strain of Lactobacillus plantarum that breaks down gluten, the insoluble protein in wheat flour, while supporting digestive health. Developed through joint research with government-funded institutes, it was patented in 2021 for its effectiveness in gluten degradation.
Studies have shown that MB0601 not only breaks down gluten efficiently but also supports digestion by increasing the hormone gastrin and boosting digestive enzymes such as pancreatic amylase, which helps break down carbohydrates.
This patented strain can be applied to noodles, dairy products, pizza, bread, and other wheat-based foods. By making it possible to produce gluten-degraded versions of these foods on a large scale, MB0601 offers a valuable solution for people with gluten intolerance, gluten sensitivity, or gluten-related allergies, making wheat-based foods easier to enjoy.
Strain
Lactobacillus plantarum MB0601
Type
Live strain
Specification
10^6 ~ 10^11 CFU/g
Registered Applications
Probiotics (health functional foods), general food additives
Patent (1)
Title: Lactobacillus plantarum MB0601 strain with gluten-degrading properties and its applications
DS0508
DS0508 is a patented probiotic strain developed for its ability to help prevent or improve obesity by promoting the browning of fat cells. This technology was licensed exclusively to us by a government-funded research institute.
Browning is the process where white fat cells, which store energy, are converted into brown fat cells, which burn energy, produce heat, and support balance in the body. Studies have shown that DS0508 activates energy use, prevents fat buildup, reduces fat cell size, and lowers blood lipid levels including total cholesterol and LDL. These findings indicate that DS0508 may help limit weight gain and improve metabolic health, making it a promising solution for managing obesity.
Strain
Lactobacillus rhamnosus DS0508
Type
Live strain
Specification
10^6 ~ 10^11 CFU/g
Registered Applications
Probiotics (health functional foods), general food additives
Patent (1)
Title: Novel Lactobacillus rhamnosus strain DS0508 with preventive or therapeutic effects on obesity and its applications
Publications (2)
1) Bifidobacterium longum DS0956 and Lactobacillus rhamnosus DS0508 culture-supernatant ameliorate obesity by inducing thermogenesis in obese-mice. Beneficial Microbes (2020).
KR-050L
KR-050L is a patented probiotic strain licensed exclusively to us by a government-funded research institute. It has been developed for versatile applications in food ingredients, additives, cosmetics, and pet feed, and is recognized for its potential in the prevention and treatment of inflammatory diseases.
Research has shown that KR-050L reduces inflammation by suppressing substances that trigger it in the body. In studies, KR-050L alleviated symptoms of atopic dermatitis in mice and demonstrated the ability to improve both intestinal inflammation and related conditions. These findings highlight its broad therapeutic potential.
Strain
Lactococcus lactis KR-050L
Type
Live strain
Specification
10^6 ~ 10^11 CFU/g